Skip to main content

Table 2 The development of SIRS and sepsis in the patient sample

From: Resuscitation with polymeric plasma substitutes is permissive for systemic inflammatory response syndrome and sepsis in multiply injured patients: a retrospective cohort study

 

No colloids

Colloids <5L/48h

Colloids >5L/48h

P value

SIRS admission

2.1 ± 1.2

2.2 ± 1.1

2.6 ± 1.1

<0.001

SIRS maximum

1.9 ± 1.4

2.4 ± 1.2

3.2 ± 0.9

<0.001*

SIRS day of maximum

2.2 ± 3.6

3.1 ± 4.4

5.9 ± 5.7

<0.001*

Sepsis (% of each group)

10

16

36

<0.001

Day of sepsis onset

7.9 ± 7.1

6.4 ± 5.4

9.1 ± 5.7

<0.001

Septic shock (% of each group)

3

2

9

<0.001

  1. Patients not receiving colloids vs. receiving colloids <5L/48h vs. colloids >5L/48h are compared. The sequence of SIRS development, sepsis, and the onset of sepsis and septic shock are shown in the investigated patient sample
  2. * ANOVA
  3. Kruskal–Wallis
  4. Significant if P < 0.05